<DOC>
	<DOCNO>NCT02462720</DOCNO>
	<brief_summary>The purpose study evaluate pain patient experience follow treatment varicose vein Varithena® compare radiofrequency ablation .</brief_summary>
	<brief_title>COMFORT : A Multicenter , Open-label , Randomized , Crossover Study</brief_title>
	<detailed_description>A study evaluate pain follow treatment varicose vein patient treat Varithena® treat RFA .</detailed_description>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Polidocanol</mesh_term>
	<criteria>1 . Men woman ; age 18 75 year 2 . Bilateral incompetence SFJ ( reflux &gt; 1 second duplex ultrasonography ) associate incompetence GSV legs 3 . GSV diameter &gt; 5 mm measure superficial epigastric vein 10 cm SFJ stand position legs 4 . Eligible receive RFA treatment Varithena® treatment 5 . CEAP C2C5 ( inclusive ) 6 . Patient participate usual work home activity change anticipate duration study 7 . Ability comprehend sign inform consent complete study questionnaire write English 8 . Ability reliably use electronic diary record pain analgesic/opioid use accordance protocol 1 . Prior GSV treatment either leg 2 . Nonvenous source pain either leg could confound result study 3 . Use chronic analgesic opiate medication medical history could result regular use pain medication study 4 . History deep vein thrombosis , pulmonary embolism stroke , include evidence prior active DVT duplex ultrasound 5 . Deep venous reflux unless clinically insignificant comparison superficial reflux 6 . Inability wear postprocedure compression bandage stocking 7 . Reduced mobility ( unable walk unaided 5 minute per wake hour ) 8 . Major surgery , prolong hospitalization pregnancy within 3 month screen 9 . Major coexist disease ( e.g. , malignancy ; pulmonary disease ; renal hepatic insufficiency ; serious skin disease/condition may compromise ability patient comply compression protocol , etc . ) 10 . Contraindications Varithena® ( e.g. , acute thromboembolic disease ) RFA accord manufacturer 's prescribe information 1 . Varithena® contraindication due know allergy polidocanol 2 . RFA contraindication due vein large 3 . RFA Contraindication due vein tortuous 11 . Known allergic response polidocanol and/or multiple allergic reaction 12 . Current history alcohol drug abuse 13 . Pregnant lactate woman 14 . Women childbearing potential use effective contraception least one month prior study treatment and/or unwilling continue birth control duration study 15 . Participation clinical study involve investigational pharmaceutical product device within 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>